Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
종목 코드 EKSO
회사 이름Ekso Bionics Holdings Inc
상장일Apr 10, 2013
CEODavis (Scott G)
직원 수61
유형Ordinary Share
회계 연도 종료Apr 10
주소101 Glacier Point
도시SAN RAFAEL
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94901
전화15109841761
웹사이트https://eksobionics.com/
종목 코드 EKSO
상장일Apr 10, 2013
CEODavis (Scott G)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음